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JNC7 guideline 2017 ACC/AHA guideline
Prevalence of hypertension, % Number of US adults with hypertension, millions
13.7% 31.1 million
Muntner et. al., Journal of the American College of Cardiology (2018)
Muntner et. al., Circulation (2018)
An additional 12% of US adults have elevated BP (systolic BP 120-
129 mm Hg and diastolic BP <80 mm Hg) and are at high risk of 
developing HBP, and among those taking antihypertensive 
medication, 53% have uncontrolled HBP.
Population High Blood Pressure Statistics in the US
1. Awareness of HBP increased from 70% in 1999-2000 to 85% in 2013-2014, but then 
declined to 77% in 2017-2018.  
2. The prevalence of controlled HBP increased between 1999-2000 and 2007-2008, did 
not significantly change from 2007-2008 through 2013-2014 (54%), and subsequently 
decreased to 44% in 2017-2018.  
3. Disparities in controlled HBP have been reported among persons who are young (18-44 
years), non-Hispanic Black, uninsured, and lack access to a usual healthcare facility. 
4. As of 2017, cardiovascular disease remains the leading cause of death in the US, with 
859,125 deaths, which, when combined with 146,383 deaths from stroke exceeds 1 
million deaths annually or 2,754 deaths per day.   
5. It is also recently well documented at the time of this presentatinon that people with 
hypertension may be at increased risk for severe illness from COVID-19. 
This HEDIS Measure
Assesses adults 18–85 years of age who had a diagnosis of hypertension and 
whose blood pressure was adequately controlled based on the following 
criteria: 
◾Adults 18-59 years of age whose blood pressure was <140/90 mm Hg.
◾Adults 60-85 years of age, with a diagnosis of diabetes, whose blood 
pressure was <140/90 mm Hg.
◾Adults 60-85 years of age, without a diagnosis of diabetes, whose blood 
pressure was <150/90 mm Hg. (Lowered to < 140/90 in 2018)
3/17/2021
HEDIS Controlling High Blood Pressure 1999-2018
Measuring what seems to matter doesn't seem to matter.....
Commercial Medicaid Medicare
HMO PPO HMO HMO PPO
2018 61 49 59 70 69
2017 62 54 57 71 72
2016 62 55 57 70 70
2015 61 53 55 68 66
2014 64 57 57 71 69
2013 64 58 57 66 63
2012 63 57 56 64 59
2011 65 58 57 64 61
2010 63 57 56 62 56
2009 64 48 55 60 55
2008 63 56 59
2007 62 53 58
2006 60 49 53 57 51
2005 69 61 62 66 61
2004 67 61 65
2003 62 59 61
2002 58 52 57














1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019
Commercial HMO Commercial PPO Medicaid HMO
Medicare HMO Medicare PPO
Percentage of patients with BP Control
Only 30% if Target dropped from 140/90  
to < 130/80 for ACC/AHA Stages 1 and 2
CAUTION: THIS MEASURE EXCLUDES ACC/AHA Stage 1 HBP!! 
Hypertension Expenditures in the United States
1. National medical costs associated with hypertension are estimated to account 
for about $131 billion in annual healthcare expenditure averaged over 12 years 
from 2003 to 2014.
2. Individuals with hypertension face nearly $2000 higher annual healthcare 
expenditure compared with their non-hypertensive peers.
3. The incremental cost associated with hypertension for US adults has remained 
steady from 2003 to 2014.
4. Expenditures associated with hypertension are rapidly shifting from inpatient to 
outpatient settings.
5. This warrants intense effort toward hypertension prevention and management. 
(J Am Heart Assoc. 2018;7:e008731. DOI: 10.1161/JAHA.118.008731.)
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A Comprehensive, Guideline-Based System of Care for People with High Blood Pressure
Perform Accurate
BP Measurement
Identify & Address Social 
Determinants of Health
Assess and Reduce ASCVD Risk 
through Shared Decision Making 
Enable and Ensure Team Based Care
& Concomitant Care Delivery Redesign
Effectively Deploy Digital Health 
Designed to Improve Patient Centered Care Coordination
Engage and Activate Health System, Payer and Employer
Leadership for Organizational & Financial Support at Every Level
Continuously Use Transparent Evidence-based, Standardized Performance, 
Quality and Structural Measurement and Improvement to Assess Progress
Insist on Effective Shared Accountability at All Levels of the Health System for 
Ensuring Access, Infrastructure, and Coverage (Including Proper Payment)
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• Vice-Chair, ACC/AHA 2017 Guideline for the Prevention, Detection, 
Evaluation and Management of High Blood Pressure in Adults
• Chair, 2018  AHA Scientific Statement on Resistant Hypertension
• Member, 2019 AHA Scientific Statement on Blood Pressure 
Measurement
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of Medicine
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HYPERTENSION
• World’s leading risk factor for morbidity and mortality.
• Ranks first worldwide in disability-adjusted life years 
(7%). 
• Affects 27% of the world’s adult population –
exceeding 1.4 billion people.
• Prevalence 32% in U.S. (72 million adults), or 46% (103 
million) using 2017 ACC/AHA guideline.
• The most common reason for visiting a physician for 
ongoing care in the U.S.















































































































































































































Unusual DBP (mm Hg)
Diastolic blood pressure
RISK OF HYPERTENSION
BP is continuously related to risk of fatal stroke, ischemic heart 
disease and non-cardiac vascular disease down to 115/75 mm Hg:
Lewington S et al. Lancet. 2002;360:1903-1913
16
Estimated Risk of BP-related Coronary Heart Disease by Level of Systolic Blood Pressure  
Experience during an average of 11.6 years of follow-up in 347,978 adults
screened for entry into the Multiple Risk Factor Intervention Trial
Adapted from Stamler J et al. Arch Intern Med. 1993;153:598-615.
130-139 category
> 20% of BP-related risk
130-139 category
almost double risk




RISK REDUCTION WITH BP CONTROL
• Risk of CVD can be greatly reduced with effective antihypertensive 
therapy.
• A 10 mm Hg lower systolic or 5 mm Hg lower diastolic BP would 
predict a 40% reduction in stroke risk and a 30% reduction in 
ischemic heart disease risk.
• Risk is reduced even with as little as a 2 mm Hg BP reduction:
Therefore, every mm Hg in blood 
pressure lowering can be of potential 
clinical importance.
From JNC-VII


















• Blood Pressure should be based on an average of ≥2 careful readings 
on ≥2 occasions.
Whelton PK, Carey RM, et al. Hypertension. J Am Coll Cardiol. 2018;71:2199-2269.
Area of
difference
• The patient should be relaxed, sitting in a chair with 
feet flat on floor and back supported. 
• The patient should be seated for 3–5 min without 
talking or moving around before recording the first BP 
reading. 
• The patient should avoid caffeine, exercise, and 
smoking for at least 30 min before measurement.
• Ensure that the patient has emptied his/her bladder.
• Neither the patient nor the observer should talk during 
the rest period or measurement.
• Remove all clothing covering the location of cuff 
placement.
• Measurements made while the patient is sitting on an 
examining table do not fulfill these criteria.
PREPARATION FOR BP MEASUREMENT
Muntner P, Shimbo D, Carey RM et al.  Hypertension. 2019.73:e35-e66.;
How to Measure your Blood Pressure at Home
20
Follow These Steps for an Accurate Blood Pressure Reading
Avoid caffeine, cigarettes and other 
stimulants 30 minutes before you 
measure your blood pressure.
Wait at least 30 minutes after a meal.
If you’re on blood pressure 
medication, measure your 
BP before you take your medication.
Empty your bladder beforehand.
Find a quiet space where you can sit 
comfortably without distraction.
Rest for five minutes while in position 
before starting.
Take two or three measurements, 
one minute apart.
Keep your body relaxed and in 
position during measurements.
Sit quietly with no distractions during 
measurements—avoid conversations, 
TV, phones and other devices.
Record your measurements 
when finished.
PREPARE1 POSITION2 MEASURE3
This Prepare, position, measure handout was adapted 
with permission of the American Medical Association and 
The Johns Hopkins University. The original copyrighted 
content can be found at https://www.ama-assn.org/ama-
johns-hopkins-blood-pressure-resources. 
Put cuff on 
bare arm, 
above elbow 
at mid-armPosition arm 




palm up, with 
muscles 
relaxed
Sit with legs 
uncrossed






APP Store: ASCVD Risk Estimator Plus
ACC/AHA POOLED COHORT EQUATIONS
To estimate the 10-year risk of ASCVD
Based on age, race, sex, total cholesterol, LDL 
cholesterol, HDL cholesterol, treatment with a 
statin, systolic BP, treatment for hypertension, 
history of diabetes, current smoker, aspirin 
therapy 


































































CVD EVENTS AVOIDED BY BASELINE RISK 
AND MAGNITUDE OF SBP LOWERING
Sundstrom et al. Lancet. 2014;384:591–598











(BP >140/90 mm Hg)
BP THRESHOLDS AND RECOMMENDATIONS 
FOR TREATMENT AND FOLLOW UP
























Clinical CVD or 
estimated 10 y 
ASCVD risk ≥ 10%
YesNo
Non-pharmacologic 
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Measure 
No.








PM-1a ACC/AHA Stage 2 High Blood Pressure Control Systolic BP < 140 mm Hg + 1A
PM-1b ACC/AHA Stage 2 High Blood Pressure Control Systolic BP < 130 mm Hg + 1A/IIaC-EO
PM-2 ACC/AHA Stage 1 High Blood Pressure Control Systolic BP < 130 mm Hg + 1A
PM-3 ACC/AHA Stage 2 and Stage 1 High Blood Pressure Control Systolic BP < 130 
mm Hg (PM-1b + PM-2 Composite)
+ + 1A/IIaC-EO
PM-4 Nonpharmacological interventions for ACC/AHA Stage 2 High Blood Pressure + 1A
PM-5 Home blood pressure monitoring (HBPM) for ACC/AHA Stage 2 management + 1A
Process Quality Measures (QM)
QM-1 Nonpharmacological interventions for ACC/AHA Elevated Blood Pressure + 1A
QM-2 Nonpharmacological interventions for ACC/AHA Stage 1 High Blood Pressure + 1A
QM-3 Nonpharmacological interventions for all ACC/AHA stages of High Blood 
Pressure (PM4 + QM1 + QM2 Composite)
+ + + 1A
QM-4 Medication Adherence to Drug Therapy for ACC/AHA Stage 1 with ASCVD Risk 
≥ 10% and ACC/AHA Stage 2 High Blood Pressure
+ + 1A
QM-5 Home blood pressure monitoring (HBPM) for management of ACC/AHA Stage 
1 High Blood Pressure with ASCVD risk ≥ 10%
+ 1A
QM-6 Home blood pressure monitoring (HBPM) for management of ACC/AHA Stage 
1 with ASCVD risk ≥ 10% and ACC/AHA Stage 2 (PM-5 + QM-5 Composite)
+ + 1A
Summary of 2019 ACC/AHA Performance and Quality Measures for the Diagnosis and Management of High Blood Pressure
Measure 
No.







Structural Quality Measures (SM)
Diagnosis, Assessment and Accurate Measurement
SM-1 Use of a Standard Protocol to consistently and correctly measure Blood 
Pressure
+ + + 1C-EO
SM-2 Use of a standard process for assessing ASCVD risk (Prevention GL) + + + IB-NR
SM-3 Use of a standard process for properly screening all adults 18 years and 
older for High Blood Pressure (USPSTF)
+ + + A (USPSTF)
SM-4 Use of an Electronic Health Record to accurately diagnose and assess High 
Blood Pressure Control
+ + + 1B-NR
A Patient-Centered Approach for Controlling High Blood Pressure
SM-5 Use of a standard process to engage patients in shared decision-making, 
tailored to their personal benefits, goals and values for evidence-based 
interventions to improve control of High BP (Prevention GL)
+ + + IB-R
SM-6 Demonstration of infrastructure and personnel that assesses and 
addresses social determinants of health of patients with High Blood 
Pressure (Prevention GL)
+ + + IB-NR
Implementation of a System of Care for Patients with High Blood Pressure
SM-7 Use of Team Based Care to better manage High Blood Pressure + + + 1A
SM-8 Use of Telehealth, m-health and e-health and other digital technologies to 
better diagnose and manage High Blood Pressure
+ + + IIaA/1A
SM-9 Use of a single, standardized plan of care for all patients with High Blood 
Pressure
+ + + 1C-EO
Use of Performance Measures to Improve Care for High Blood Pressure
SM-10 Use of performance measures to improve quality of care for patients with 
High Blood Pressure
+ + IIaB-NR
Summary of 2019 ACC/AHA Structural Measures for the Diagnosis and Management of High Blood Pressure
Self-Measured Blood Pressure Monitoring (SMBP)
Shimbo, D. et al. 2020.  Circulation. 
• SMBP plus additional clinical support is more effective than usual care in lowering blood pressure 
and improving control among patients with hypertension1
• Clinical support includes:
 One-on-one counseling
 Web-based or telephonic support
 Educational classes
Shared Decision Making 
1. An approach wherein clinicians and patients share the best available evidence when faced 
with the task of making decisions, and where patients are supported to consider options to 
achieve informed preferences.”1
2. “Meeting of two experts” in the clinical encounter. 2
3. Decision aids, question prompts, motivational interviewing, visuals, and other communication 
strategies may be used 
4. Potential to advance equity and improve hypertension care. 3
1. Elwyn et al. (2012).J Gen Intern Med. 
2. Elwyn et al. (2017).BMJ. 
3. Langford et al. (2019). Ethn Dis
Social Determinants of Health
1. Marmot M et al. (2008). Lancet 
2. Havranek EP et al. (2015). Circulation
3. Commodore-Mensah Y et al.(2021). Am J Hypertens.
• The circumstances in which people are born, grow, live, work, and age, and the systems put in place 
to deal with illness. 1
• The AHA has identified key SDoH including race, ethnicity, racism and discrimination, 
socioeconomic status, geography, housing, and healthcare access, are associated with the 
prevalence and control of HBP and CVD outcomes. 2
• Among 21,664 adults in NHANES (2011-2018)
 HTN  and stage 2 HTN prevalence higher among Black and Asian than White adults.
 Black adults had lower prevalence of controlled BP than White adults. 
 Compared to college graduates, men and women with less education had a higher prevalence 
of hypertension and stage 2 hypertension. 
 Men and women with no routine place for healthcare had lower prevalence of controlled BP 
than those who had a routine place for healthcare. 
 Uninsured men and women had lower prevalence of controlled BP than those insured. 
• Program Director for the American Heart Association’s and 
American Medical Association’s National Initiative for Control 
Blood Pressure, Target: BP
• AHA Cooperative Agreement Team Member for National 
Hypertension Control Initiative funded by the Office of 
Minority Health and the Heath Resource Services 
Administration
• National Advisory Board Member, Johns Hopkins 
University School of Nursing
• Public Member, Accreditation Council of Graduate 
Medical Education, Family Medicine Review Committee
• Medical-surgical, telemetry nurse and public health 
professional
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Creating Better Systems of Care
 Elevating the Evidence
 Translating the Evidence into Practice
 Leveraging Resources, Processes, & Performance


















SECTION 12 COR LOE Recommendations
MEDICATION 
ADHERENCE
1 B-R In adults with hypertension, dosing of antihypertensive medication once daily rather than multiple times daily is beneficial to improve 
adherence.S12.1.1-1–S12.1.1-3




Effective behavioral and motivational strategies to achieve a healthy lifestyle (ie, tobacco cessation, weight loss, moderation in alcohol intake, 
increased physical activity, reduced sodium intake, and consumption of a healthy diet) are recommended for adults with hypertension.S12.1.2-1,S12.1.2-2
TEAM-BASED CARE I A A team-based care approach is recommended for adults with hypertension.S12.2-1–S12.2-7
EHRs & PATIENT 
REGISTRIES
I B-NR Use of the EHR and patient registries is beneficial for identification of patients with undiagnosed or undertreated hypertension.S12.3.1-1–S12.3.1-3
I B-NR Use of the EHR and patient registries is beneficial for guiding quality improvement efforts designed to improve hypertension control.S12.3.1-1–S12.3.1-3




Use of performance measures in combination with other quality improvement strategies at patient-, provider-, and system-based levels is 
reasonable to facilitate optimal hypertension control.S12.4.1-1–S12.4.1-3
QI STRATEGIES IIa B-R





Financial incentives paid to providers can be useful in achieving improvements in treatment and management of patient populations with 
hypertension.S12.5-1–S12.5-3
IIa B-NR
Health system financing strategies (eg, insurance coverage and copayment benefit design) can be useful in facilitating improved medication 
adherence and BP control in patients with hypertension.S12.5-4
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
SECTION 12  Strategies to Improve Hypertension Treatment and Control
https://doi.org/10.1161/HYP.0000000000000065Hypertension. 2018;71:e13–e115
Translating Evidence into Practice
Esperanza Health Centers Chicago, IL
 HRSA-funded Health Center
 75% pts below 100% poverty level 
 Nearly half uninsured
 Team-based care
 EMR performance data
 Socio-cultural relevant practices
 82% BP Control Rate 




 16 Family Medicine Clinics
 Measure Accurately 
 Act Rapidly 
 Partner with Patients 
 Leading metrics 
 6 mo practice facilitation
















 Every 6-12 months in BP 
measurement
Purchase 
 Validated office, home BP 
devices 
 US Blood Pressure Validated 
Device Listing (VDL™)
Maintain
 Calibrate as directed
Team
 Diverse, trusted voices
 Defined roles
Processes 
 SMBP, lifestyle program
 Defined info and workflow
EHR
 Find & track patients
 Capture representative BPs
 Prompt tx intensification, 1 pill qday
https://www.ahajournals.org/doi/full/10.1161/HYP.0000000000000087
http://www.validatebp.org/ or Hypertension Canada, Stride BP, British and Irish Hypertension Society
Measure 
 Leading / Lagging 
 Performance, process quality, 
structural measures
Evaluate





Leveraging Resources, Processes, & Performance
Circ Cardiovasc Qual Outcomes. 2019;12:e000057. DOI: 10.1161/HCQ.0000000000000057
120
80
Aligning Science & Policy
“p” Institutional policy 
 Device procurement
 Team training standards
 EHR capabilities and standards
 Employer sponsored health 
coverage
“P” Coverage & Reimbursement Policy
Medicare
 SMBP CPT codes:  Education (99473), Monitoring/Mgmt (99474)
 Requested National Coverage Determination for home BP 
monitors
Medicaid
 Growing, nuanced coverage/reimbursement for HCPCS, CPT 
code
 2020-21: AZ, GA, IA, IL, KS, MA, NC, NY, OR, TX, WA
Commercial
 Private (20), Medicaid FFS (10), MCO (7), Medicare Adv (5)
https://targetbp.org/tools_downloads/new-cpt-codes-to-cover-self-measured-blood-pressure-smbp/
https://chronicdisease.org/resource/resmgr/website-2020/consultants/cvh/smbp/synthesis_of_smbp_coverage_f.pdf
A Comprehensive, Guideline-Based System of Care for People with High Blood Pressure
Perform Accurate
BP Measurement
Identify & Address Social 
Determinants of Health
Assess and Reduce ASCVD Risk 
through Shared Decision Making 
Enable and Ensure Team Based Care
& Concomitant Care Delivery Redesign
Effectively Deploy Digital Health 
Designed to Improve Patient Centered Care Coordination
Engage and Activate Health System, Payer and Employer
Leadership for Organizational & Financial Support at Every Level
Continuously Use Transparent Evidence-based, Standardized Performance, 
Quality and Structural Measurement and Improvement to Assess Progress
Insist on Effective Shared Accountability at All Levels of the Health System for 
Ensuring Access, Infrastructure, and Coverage (Including Proper Payment)
The “Blueprint For Change” to control High Blood Pressure
Health system and payer leadership (managerial, clinical and operational) should:
1. commit appropriate resources to ensure accurate BP measurement and the appropriate use of validated, calibrated BP 
monitoring devices consistent with current clinical practice guidelines throughout the entire healthcare system.
2. strongly encourage and support home BP monitoring (HBPM) of all patients with hypertension and should ensure accurate 
out-of-office measurements and secure data collection. 
3. commit appropriate resources to ensure that adults 40-75 years of age are consistently evaluated for ASCVD risk estimation 
and subsequent guideline-based opportunities for prevention. 
4. should strongly encourage and promote assessment and addressing the Social Determinants of Health (SDoH) in clinical 
settings for patients with HBP. 
5. implement a standardized process of evidence-based interventions designed to engage patients and their clinicians in shared 
decision-making (SDM) and tailored to their personal benefits, goals, and values to improve control of HBP. 
6. implement team-based care designed to fully support and achieve successful care for people with HBP in accordance with the 
guideline-based “Blueprint for Change” recommendations 1-5 noted above. 
7. actively collaborate at the local, regional, and national levels to create and support a coordinated system of guideline-based 
care delivery for adults with HBP as outlined in this Blueprint for Change.
The 2019 AHA/ACC Clinical Performance and Quality  Measures (CPQMs) for Adults with HBP provides an excellent framework 
for health systems and payers to evaluate and monitor the success of collaborative “Blueprint for Change” initiatives designed to 
improve guideline-based care delivery for more than 100 million Americans with HBP.
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